Quench targets lupus and rare diseases with R&D into new drug classQuench Bio has emerged from stealth mode with $50 million of committed funding, bidding to be the first Share XQuench targets lupus and rare diseases with R&D into new drug classhttps://pharmaphorum.com/news/uk-biotech-targets/
